Skip to main content
Equibles
INGN logo

INGN · Inogen Inc

Track INGN — free

Use INGN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$5.39 +0.06 (+1.13%) At close · Sep 2
Russell 2000 member Rebalance outlook locked
Market Cap
$141.45M
Shares
26.54M

INGN metrics

67 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$5.33
Market cap
$141.45M

Price action

19 metrics
Price change (1W)
-3.8%
Price change (30D)
-20.6%
Price change (3M)
-12.5%
Price change (6M)
-14.2%
Price change (YTD)
-20.7%
Price change (1Y)
-33.3%
Trailing year
Price change (5Y)
-91.2%
52-week high
$8.95
52-week low
$5.33
Change from 52-week high
-40.4%
Change from 52-week low
+0.0%
Annualized volatility
42.4%
Beta
0.5
RSI (14D)
27.6
Price vs SMA 50
-14.4%
Price vs SMA 200
-16.9%
Avg volume (3M)
261,171
Relative volume
1.0
Average dollar volume
$1.63M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
26.54M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.4×
reciprocal yield 250.5%
P / book
0.8
reciprocal yield 123.6%
FCF yield
-3.5%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
14.8%

Historical valuation

8 metrics
P / E historical average (3Y)
77.5×
reciprocal yield 1.3%
P / E historical average (5Y)
77.5×
reciprocal yield 1.3%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
44.5%
Operating margin
-8.7%
Trailing 12 months
Net margin
5.9%
Gross profit (TTM)
$157.69M
Operating profit (TTM)
−$30.85M
Net income (TTM)
$20.90M
Trailing 12 months
Diluted EPS (TTM)
$-0.90
FCF margin
-1.4%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-221.98

Growth

11 metrics
Revenue growth YoY
+3.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$354.30M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.3%
Year over year · more shares
Revenue CAGR (3Y)
-2.6%
Revenue CAGR (5Y)
+2.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
12.0%
Return on assets
7.3%
Debt / equity
—
Current ratio
2.7
EBITDA (TTM)
−$11.04M
Free cash flow (TTM)
−$4.98M
Quick ratio
2.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$87.28M
Total assets
$285.57M
Total debt
$160,000

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$2.52M
Capital expenditures (TTM)
$2.47M
R&D (TTM)
$21.12M
SG&A (TTM)
—
Stock compensation (TTM)
$7.29M
R&D / revenue
6.0%
Stock compensation / revenue
2.1%

Ownership (13F)

3 metrics
13F filers
129
13F filer change QoQ
+3
Institutional ownership
72.5%

Short interest

3 metrics
Short interest
5.4%
Latest settlement · 4.9 days to cover
Days to cover
4.9d
Short-squeeze score
62 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$72,146
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1294133 CUSIP 45780L104 13F (30d) 110 filings 110 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)